#cholangiocarcinoma résultats de recherche
🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
![HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme
🇬🇧 Evidence from a national pilot initiative
📊 Refined selection & transplant outcomes
💡 Expanding treatment frontiers in iCCA care
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G43_3bTbQAQ_zZa.png)
![HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme
🇬🇧 Evidence from a national pilot initiative
📊 Refined selection & transplant outcomes
💡 Expanding treatment frontiers in iCCA care
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G43_4xNbQAA-Slx.jpg)
![HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme
🇬🇧 Evidence from a national pilot initiative
📊 Refined selection & transplant outcomes
💡 Expanding treatment frontiers in iCCA care
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G43_5k_bQAE3rZt.jpg)
![HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme
🇬🇧 Evidence from a national pilot initiative
📊 Refined selection & transplant outcomes
💡 Expanding treatment frontiers in iCCA care
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G43_6VXaAAEktou.jpg)
🚨#ESMO25 #Cholangiocarcinoma –Phase 2–3 ZSAB-neoGOLP trial (Toripalimab + Lenvatinib + GEMOX) in resectable high-risk iCCA 🎯 mEFS 18.0 vs 8.7 mo 💥 ORR 54.4% | MPR 19.3% | pCR 4.5% ✨ OS trend favoring neoadjuvant arm (NE vs 31.4 mo) A strong neoadjuvant signal! Sometimes the…
Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma #drainage authors.elsevier.com/sd/article/S25…
📽️ Ever heard of #cholangiocarcinoma? It’s a rare cancer that affects the bile ducts — and knowing the basics could make a big difference. Learn about the symptoms to look out for.
Kicking off the 7th Annual #Cholangiocarcinoma Summit in Scottsdale, AZ. 🌵 Together, we’re building knowledge, community, and hope.
Unresectable intrahepatic #cholangiocarcinoma conversion/transplantation is our #1 MDT mission. 🤝 This evidence is so welcome. ✨ Inadequate FLR, tumor response, and biological test-of-time are addressed with neoadjuvant #Y90 radiation lobectomy. 🌳 We are exploring this…
💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
![HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes
🏥 Evolution of surgical strategies
📊 Impact on prognosis and clinical practice
💡 Insights guiding future guideline updates
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G4jXR67a8AAnbeq.png)
![HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes
🏥 Evolution of surgical strategies
📊 Impact on prognosis and clinical practice
💡 Insights guiding future guideline updates
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G4jXTcSagAANB9W.jpg)
![HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes
🏥 Evolution of surgical strategies
📊 Impact on prognosis and clinical practice
💡 Insights guiding future guideline updates
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G4jXUMpaYAAfCp-.jpg)
🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
![HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives
🧬 Precision oncology in #iCCA
🔍 Targeting driver mutations & pathways
💡 Expanding options for individualized care
🔗 [oaepublish.com/articles/2394-…]
#TargetedTherapy](https://pbs.twimg.com/media/G4yusKobkAAvn0x.png)
![HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives
🧬 Precision oncology in #iCCA
🔍 Targeting driver mutations & pathways
💡 Expanding options for individualized care
🔗 [oaepublish.com/articles/2394-…]
#TargetedTherapy](https://pbs.twimg.com/media/G4yutq-bQAAnb9q.jpg)
![HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives
🧬 Precision oncology in #iCCA
🔍 Targeting driver mutations & pathways
💡 Expanding options for individualized care
🔗 [oaepublish.com/articles/2394-…]
#TargetedTherapy](https://pbs.twimg.com/media/G4yuvDQa8AAvXhH.png)
![HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives
🧬 Precision oncology in #iCCA
🔍 Targeting driver mutations & pathways
💡 Expanding options for individualized care
🔗 [oaepublish.com/articles/2394-…]
#TargetedTherapy](https://pbs.twimg.com/media/G4yu6SVaAAAc2gB.png)
October Issue: Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable #Cholangiocarcinoma @Yawwenyy @vanjapod rdcu.be/eLxXd @CamilleLStewart @SyedAAhmad5
We've received Orphan Drug Designation from the United States Food and Drug Administration for our oncolytic virotherapy CF33-hNIS (VAXINIA) for the treatment of #cholangiocarcinoma, a rare and aggressive form of bile tract cancer. This designation provides valuable incentives,…
Mini oral session at @myESMO #ESMO25 #BTC Tinengotinib in FGFR2 altered #Cholangiocarcinoma by @JavleMilind n=110 pts Activity in FGFR altered and FGFR refractory/relapsed CCA Phase III ongoing (recruiting at @Hospital_FJD) ☺️ #ESMOAmbassadors
Yesterday, the Scottish Parliament debated #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can read a summary of the debate and watch the recording on the AMMF website: ammf.org.uk/2025/10/31/sco…
Interested in precision medicine and #BTC #cholangiocarcinoma? Read our paper @ESMO_Open! authors.elsevier.com/sd/article/S20…
A CCA survivor thriver, his wife & his oncologist, Dr. Katie Kelley, just climbed to the top of Salesforce Tower 💪 She’s a CCF Innovation Grant recipient & Mark R. Clements Awardee—and a true partner in the climb toward a cure. #Cholangiocarcinoma #LivingBeyondDiagnosis…
Great talk by friend, colleague and awesome surgeon @laleh_melstrom reviewing conversion to surgical resection in #cholangiocarcinoma at the CCA Summit 2025 @cityofhope @CityofHopeSurg @curecc
Very moving story by #CynthiaMitchell at @curecc with #ccfac25 coming to an end How to find “the joy that exists in our life despite the darkness” when someone is diagnosed with #cholangiocarcinoma and all the #UnexpectedGifts she found over the last years 💚💚
Program Chair @kspencer725 kicking off the 7th Annual #Cholangiocarcinoma Summit in AZ 🌵 👀 forward to 2d of innovation and collaboration @curecc @CcaEns @AmplityHealth
🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
Please consider applying to this great program if interested in #cholangiocarcinoma globally 🌎 #mentorship #payitforward #nextgeneration
📢 Deadline Extension: The Precision-BTC-Network, in collaboration with ENS-CCA and @curecc's International Cholangiocarcinoma Research Network, invites applications for its Mentorship Program. NEW application deadline: November 7 🌐lnkd.in/d6aFK_DA
Unfortunately only 15–25% of patients with #cholangiocarcinoma qualify for second-line therapy. But what are the current treatment options for these patients, what therapies are on the horizon, and can biomarkers help to improve outcomes? 👉 buff.ly/Ow5YL6A #OncTwitter
Important feature #intrahepatic #cholangiocarcinoma = desmoplastic reaction. May extend beyond the tumor in portal triads, hepatic hilum and extrahepatically along hepatic veins. Increased duration and difficulty of surgery!👇 #oncsurgery @SSATNews @AHPBA @IHPBA
👏 This paper investigates the diverse roles of collagen molecules in #intrahepatic #cholangiocarcinoma, revealing their impact on tumor growth, invasion, and remodeling of the extracellular matrix. @DrNguyenhiep @timnewhook19 @HalletJulie @FlavioRochaMD @skmaithel @VautheyMD
Yesterday, the Scottish Parliament debated #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can read a summary of the debate and watch the recording on the AMMF website: ammf.org.uk/2025/10/31/sco…
🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
At 5pm today, the Scottish Parliament will debate #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can watch the debate live online, or as an on-demand recording. 🔗 Watch now | scottishparliament.tv #RethinkLiverCancer #Scotland #debate
📅 New #Review in #Vol32_Iss10 📑 "Neoadjuvant Strategies for Patients with Resectable Biliary Tract Cancers: A Review" ✍️ by Chelsea R. Olson et al. 📍 Access the full paper here: brnw.ch/21wX3yc #Cholangiocarcinoma #NeoadjuvantTherapy
💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
👏 This narrative review summarizes recent progress in liver #transplantation for #intrahepatic #cholangiocarcinoma, highlighting refined selection criteria, improved outcomes, and future directions in patient management. @CalderonNo81257 @frandesanti @TorzilliGuido @pashtoonkasi
🩹 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Latest Advances and Evolving Perspectives 🧬Refined transplant selection & outcomes 🧬 Integration of systemic and locoregional therapies 🧬 Redefining transplantation in iCCA management 🔗 [oaepublish.com/articles/2394-…]
![HepatomaRes's tweet image. 🩹 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Latest Advances and Evolving Perspectives
🧬Refined transplant selection & outcomes
🧬 Integration of systemic and locoregional therapies
🧬 Redefining transplantation in iCCA management
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G4eYMzOa8AEPeQQ.png)
🩹 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Latest Advances and Evolving Perspectives 🧬Refined transplant selection & outcomes 🧬 Integration of systemic and locoregional therapies 🧬 Redefining transplantation in iCCA management 🔗 [oaepublish.com/articles/2394-…]
🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]
![HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma
💡 #Multimodal downstaging strategies
💡 Expanding surgical eligibility in #iCCA
💡 Toward better prognosis through tailored therapy
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G4eWu_-bUAAHLr6.png)
![HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma
💡 #Multimodal downstaging strategies
💡 Expanding surgical eligibility in #iCCA
💡 Toward better prognosis through tailored therapy
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G4eWwoDaYAA92Vb.jpg)
![HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma
💡 #Multimodal downstaging strategies
💡 Expanding surgical eligibility in #iCCA
💡 Toward better prognosis through tailored therapy
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G4eWyMZaQAA2fHT.png)
![HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma
💡 #Multimodal downstaging strategies
💡 Expanding surgical eligibility in #iCCA
💡 Toward better prognosis through tailored therapy
🔗 [oaepublish.com/articles/2394-…]](https://pbs.twimg.com/media/G4eWzX0a8AI9jui.png)
📺 Dr. Matthew Krebs of @OfficialUoM describes the rationale behind his study presented at #ESMO25 that explored the next-generation KRAS G12C inhibitor #divarasib in pancreatic cancer and #cholangiocarcinoma: buff.ly/bLYl8HE
🙌This paper reviews the current evidence and controversies surrounding #liver #transplantation for perihilar #cholangiocarcinoma, exploring patient selection, outcomes, and future directions. @charcotorra @cdopazo1 @Eric_Vibert @nigeljamieson @RachelGuest1 @BasGrootKoerkam
🩺 Liver Transplantation for Perihilar #Cholangiocarcinoma: Do We Need to Move Forward? 🧬 Evolving criteria for transplant candidacy 📊 Comparative outcomes & #clinical evidence 💡 Defining next steps in #CCA management 🔗 [oaepublish.com/articles/2394-…] #TranslationalMedicine
![HepatomaRes's tweet image. 🩺 Liver Transplantation for Perihilar #Cholangiocarcinoma: Do We Need to Move Forward?
🧬 Evolving criteria for transplant candidacy
📊 Comparative outcomes & #clinical evidence
💡 Defining next steps in #CCA management
🔗 [oaepublish.com/articles/2394-…]
#TranslationalMedicine](https://pbs.twimg.com/media/G4UuEV-bsAANxWZ.png)
![HepatomaRes's tweet image. 🩺 Liver Transplantation for Perihilar #Cholangiocarcinoma: Do We Need to Move Forward?
🧬 Evolving criteria for transplant candidacy
📊 Comparative outcomes & #clinical evidence
💡 Defining next steps in #CCA management
🔗 [oaepublish.com/articles/2394-…]
#TranslationalMedicine](https://pbs.twimg.com/media/G4UuFzQbAAA5imj.jpg)
![HepatomaRes's tweet image. 🩺 Liver Transplantation for Perihilar #Cholangiocarcinoma: Do We Need to Move Forward?
🧬 Evolving criteria for transplant candidacy
📊 Comparative outcomes & #clinical evidence
💡 Defining next steps in #CCA management
🔗 [oaepublish.com/articles/2394-…]
#TranslationalMedicine](https://pbs.twimg.com/media/G4UuGrlaAAAGCso.jpg)
![HepatomaRes's tweet image. 🩺 Liver Transplantation for Perihilar #Cholangiocarcinoma: Do We Need to Move Forward?
🧬 Evolving criteria for transplant candidacy
📊 Comparative outcomes & #clinical evidence
💡 Defining next steps in #CCA management
🔗 [oaepublish.com/articles/2394-…]
#TranslationalMedicine](https://pbs.twimg.com/media/G4UuHiKa4AE9KdF.jpg)
🩺 Liver Transplantation for Perihilar #Cholangiocarcinoma: Do We Need to Move Forward? 🧬 Evolving criteria for transplant candidacy 📊 Comparative outcomes & #clinical evidence 💡 Defining next steps in #CCA management 🔗 [oaepublish.com/articles/2394-…] #TranslationalMedicine
Zenocutuzumab gains #FDA breakthrough therapy designation for advanced #cholangiocarcinoma, showcasing promising trial results and potential targeted treatment options. hubs.li/Q03QcT1y0
🧬 Signaling and Molecular Networks in #Cholangiocarcinoma Initiation and Progression 🔗 Developmental & inflammatory crosstalk 🔥 Key oncogenic signaling cascades 💡 Pathways guiding targeted interventions 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer #Inflammation
![HepatomaRes's tweet image. 🧬 Signaling and Molecular Networks in #Cholangiocarcinoma Initiation and Progression
🔗 Developmental & inflammatory crosstalk
🔥 Key oncogenic signaling cascades
💡 Pathways guiding targeted interventions
🔗 [oaepublish.com/articles/2394-…]
#BileDuctCancer #Inflammation](https://pbs.twimg.com/media/G4OxpE9W4AA7U2m.png)
![HepatomaRes's tweet image. 🧬 Signaling and Molecular Networks in #Cholangiocarcinoma Initiation and Progression
🔗 Developmental & inflammatory crosstalk
🔥 Key oncogenic signaling cascades
💡 Pathways guiding targeted interventions
🔗 [oaepublish.com/articles/2394-…]
#BileDuctCancer #Inflammation](https://pbs.twimg.com/media/G4OxqL4W4AAjnba.jpg)
![HepatomaRes's tweet image. 🧬 Signaling and Molecular Networks in #Cholangiocarcinoma Initiation and Progression
🔗 Developmental & inflammatory crosstalk
🔥 Key oncogenic signaling cascades
💡 Pathways guiding targeted interventions
🔗 [oaepublish.com/articles/2394-…]
#BileDuctCancer #Inflammation](https://pbs.twimg.com/media/G4OxrAVWEAA_r6s.jpg)
Unresectable intrahepatic #cholangiocarcinoma conversion/transplantation is our #1 MDT mission. 🤝 This evidence is so welcome. ✨ Inadequate FLR, tumor response, and biological test-of-time are addressed with neoadjuvant #Y90 radiation lobectomy. 🌳 We are exploring this…
Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma #drainage authors.elsevier.com/sd/article/S25…
🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
Kicking off the 7th Annual #Cholangiocarcinoma Summit in Scottsdale, AZ. 🌵 Together, we’re building knowledge, community, and hope.
🚨#ESMO25 #Cholangiocarcinoma –Phase 2–3 ZSAB-neoGOLP trial (Toripalimab + Lenvatinib + GEMOX) in resectable high-risk iCCA 🎯 mEFS 18.0 vs 8.7 mo 💥 ORR 54.4% | MPR 19.3% | pCR 4.5% ✨ OS trend favoring neoadjuvant arm (NE vs 31.4 mo) A strong neoadjuvant signal! Sometimes the…
💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
🧭 You're their guide. We're your partner. Healthcare Providers: CCF can help you explore treatment options, connect to research, and offer trusted patient resources. Start here 👉 cholangiocarcinoma.org/physicians/ #Cholangiocarcinoma #RareCancer #Oncology #ClinicalTrials…
Phenomenal 🤩 Surgery Grand Rounds this am by Visiting Professor @Majeldoyle @WashU on rapidly evolving role of #transplantoncology for cancer #HCC #cholangiocarcinoma #CRLM 🔑 takeaways: 1) Patient selection 🧬 2) Treatment sequence/#HAI ⛽️ 3) Organ availability/allocation
🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
Glad to share that have I presented two abstracts at the CCF Conference! @curecc Thanks Dr. @LewisRobertsMD for the guidance and support. #CCFConference #cholangiocarcinoma
October Issue: Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable #Cholangiocarcinoma @Yawwenyy @vanjapod rdcu.be/eLxXd @CamilleLStewart @SyedAAhmad5
Always bittersweet to leave @curecc #ccfac25 but feeling inspired with all the progress and future directions in #cholangiocarcinoma 💚 #onward #endcancer
Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection 🌷doi.org/10.14701/ahbps… Ann Hepatobiliary Pancreat Surg 2023 May;27(2)Woo Jin Choi #Cholangiocarcinoma #Hepatectomy #Recurrence #Liver
Great talk by friend, colleague and awesome surgeon @laleh_melstrom reviewing conversion to surgical resection in #cholangiocarcinoma at the CCA Summit 2025 @cityofhope @CityofHopeSurg @curecc
October Issue: #Cholangiocarcinoma of the Middle Bile Duct: A Narrative Review @RichSchulickMD @IA_Ziogas @DimitriosMoris @AnaGleisner rdcu.be/dVB8q @BotelhoDra @SyedAAhmad5
#Grateful with @cramerthemetsfan to @lhs_cardinals_football_nj @CardinalsLHS @ltpsathletics @ltps1 #pinkout #cholangiocarcinoma @curecc #octoberis4livers
🔥💯 masterclass on future surgical perspectives for pts w/iCCA from @HopSTranCao at #EWALT2023 Inspiring leader in the fight against #cholangiocarcinoma @MDAndersonNews @VautheyMD @ccadigest @JavleMilind @curecc @CDTzeng #oncsurgery
Something went wrong.
Something went wrong.
United States Trends
- 1. Dick Cheney 13.8K posts
- 2. Today is Election Day 2,899 posts
- 3. Good Tuesday 24.3K posts
- 4. Rolex 15.3K posts
- 5. George W. Bush 6,918 posts
- 6. GO VOTE 67.1K posts
- 7. #WeTVAlwaysMore2026 1.4M posts
- 8. #Election2025 2,074 posts
- 9. Halliburton 1,025 posts
- 10. iPads N/A
- 11. Hogg 6,697 posts
- 12. Jonathan Bailey 43.7K posts
- 13. Comey 92.6K posts
- 14. Nick Smith Jr 15K posts
- 15. #LakeShow 3,494 posts
- 16. Kawhi 4,824 posts
- 17. Jake Paul 5,704 posts
- 18. Ben Shapiro 72K posts
- 19. Pacers 14.7K posts
- 20. Kyler 9,114 posts